KPRDO acknowledges Emcure’s positive response on exclusive stockist appointment for special category sales: Nandita ...

The partnership enhances Emcure’s existing diabetes portfolio and reinforces its efforts to expand access to affordable, high ...

Emcure Pharmaceuticals and Sanofi India have announced a distribution agreement. Emcure will promote Sanofi India's oral anti ...

Emcure Pharmaceuticals partners with Sanofi India to distribute and promote oral anti-diabetic products in India.

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Emcure Pharmaceuticals Ltd. and Sanofi India Limited today entered into an exclusive distribution and promotion agreement for ...

Emcure Pharma and Sanofi India announced that they entered into an exclusive distribution and promotion agreement for the latter's oral anti-diabetic products in India, effective immediately. Emcure ...

Q2 2025 saw deal value drop 62% as large-ticket M&A dried up; investors pivot to focused platforms in pharma, hospitals, ...

Emcure Pharmaceuticals made its market debut on July 10, 2024. The shares of the Pune-based company have risen 27% against ...

Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic ...

Emcure Pharmaceuticals and Sanofi India announce exclusive distribution agreement for Sanofi's oral anti-diabetic products in ...

Over 100 million Indians are living with type 2 diabetes and its complexities in India,' said Eric Mansion from Sanofi.